(NYSEMKT: INFU) Infusystem Holdings's forecast annual revenue growth rate of 6.58% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.52%.
Infusystem Holdings's revenue in 2025 is $139,886,000.On average, 7 Wall Street analysts forecast INFU's revenue for 2025 to be $3,003,229,487, with the lowest INFU revenue forecast at $2,876,588,510, and the highest INFU revenue forecast at $3,103,520,970.  On average, 7 Wall Street analysts forecast INFU's revenue for 2026 to be $3,205,242,271, with the lowest INFU revenue forecast at $3,018,548,960, and the highest INFU revenue forecast at $3,356,598,664.  
In 2027, INFU is forecast to generate $3,536,755,667 in revenue, with the lowest revenue forecast at $3,380,292,782 and the highest revenue forecast at $3,676,060,741.